Northwest Biotherapeutics reported 28.28M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agenus AGEN:US $ 14.18M 0.63M
Applied Genetic Technologies AGTC:US $ 20.43M 0.16M
AstraZeneca AZN:LN 31099M 318M
Bristol Myers Squibb BMY:US $ 44972M 419M
Celldex Therapeutics CLDX:US $ 0M 0M
Cti Biopharma CTIC:US $ 106.33M 58.95M
Cytori Therapeutics CYTX:US $ 6.33M 0.29M
Cytrx CYTR:US 0 0
Eisai 4523:JP Y 135758M 45837M
Genocea Biosciences GNCA:US $ 7.65M 1.14M
Infinity Pharmaceuticals INFI:US $ 0M 0M
Merk MRK:US $ 31794M 1308M
Mirati Therapeutics MRTX:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 28.28M 4.12M
Pfizer PFE:US $ 36301M 2135M